NEW YORK (GenomeWeb) – NeoGenomics today announced the closing of a public offering that raised $34.6 million in net proceeds.
The Ft. Myers, Fla.-based cancer genetic testing services firm offered 8.05 million shares at $4.60 per share, which included 1.05 million shares purchased by the underwriters on the offering as a result of the exercise of their overallotment option.
William Blair was the sole book-running manager, while Craig-Hallum Capital Group acted as co-lead manager. Stephens, Roth Capital Partners, Sidoti, and Dawson James were the co-managers.
NeoGenomics plans to use the proceeds for working capital, capital expenditures, and general corporate purposes, including potential acquisitions, and debt repayment, it said.